{
  "id": 20908843,
  "title": "Forget the Headlines: Novo Nordisk's (NVO) 4.6% Dividend Yield Is the Real Story for Patient Investors",
  "url": "https://urgent.news/2026/11/20/forget-the-headlines-novo-nordisks-nvo-4-6-dividend-yield-is-the-real-20908843",
  "topic": "finance",
  "section": "Finance & Markets",
  "published": "2026-11-20T13:49:00.000Z",
  "source": {
    "name": "Nasdaq Markets",
    "slug": "nasdaq-markets",
    "url": "https://www.nasdaq.com/articles/forget-headlines-novo-nordisks-nvo-46-dividend-yield-real-story-patient-investors"
  },
  "original_language": "en",
  "account": null,
  "summary": "Key PointsEli Lilly's not the only GLP-1 game in town -- Novo Nordisk has an oral pill formulation.",
  "key_points": [],
  "editors_take": null,
  "illustration": null,
  "coverage": {
    "outlets": 2,
    "also_reported_by": [
      {
        "outlet": "Motley Fool",
        "title": "Forget the Headlines: Novo Nordisk's (NVO) 4.6% Dividend Yield Is the Real Story for Patient Investors",
        "url": "https://urgent.news/2026/11/20/forget-the-headlines-novo-nordisks-nvo-4-6-dividend-yield-is-the-real",
        "published": "2026-11-20T13:29:00.000Z"
      }
    ]
  },
  "ai_generated": true,
  "disclaimer": "Summaries, key points and the editor’s take are written by software from other outlets’ reporting and may contain errors — always check the linked original."
}